Zhao et al., in 2011, demonstrated that the overexpression of miR-221 was associated with the subtype of invasive breast cancer with negative hormone receptor and resistance to the therapy instituted [18]. This evidence concerns the gene NR4A1 and invasive breast carcinoma.